BeyondSpring Inc. (BYSI) vs Context Therapeutics Inc. (CNTX)
A side-by-side comparison of BeyondSpring Inc. and Context Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BYSI
BeyondSpring Inc.
$0.72HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
CNTX
Context Therapeutics Inc.
$0.32HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
Total return — BYSI vs CNTX
growth of $100 · dividends reinvested · last 5yBYSI -95.1% (-45.4%/yr)CNTX -93.4% (-41.9%/yr)CNTX compounded faster over this window
BYSI CNTX
BYSI vs CNTX: by the numbers
- •CNTX is the larger company ($30M vs $30M market cap).
Metrics side by side
Valuation
| Metric | BYSI | CNTX |
|---|---|---|
| P/B ratio | N/A | 0.78 |
Profitability
| Metric | BYSI | CNTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -120.40% |
| ROIC | N/A | -126.84% |
Growth (annualized)
| Metric | BYSI | CNTX |
|---|---|---|
| Total return CAGR (5Y) | -44.30% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.